Henriette Vever

Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy

Daniel Eliáš, Henriette Vever, Anne‐Vibeke Lænkholm et al. · Oncogene · 2014 · 79 citations · Full text

Systems Biology, Tamoxifen Resistance, Endocrine Mechanism +10

Co-targeting CDK2 and CDK4/6 overcomes resistance to aromatase and CDK4/6 inhibitors in ER+ breast cancer

Abeer J. Al-Qasem, Carla L. Alves, Sidse Ehmsen et al. · npj Precision Oncology · 2022 · 67 citations · Full text

Breast Oncology, Chemoprevention Strategy, Cancer Biology +16

Targeting two distinct epitopes on human CD73 with a bispecific antibody improves anticancer activity

Odd Lilleng Gammelgaard, Mikkel G. Terp, Christian Renn et al. · Journal for ImmunoTherapy of Cancer · 2022 · 22 citations · Full text

MCM3 upregulation confers endocrine resistance in breast cancer and is a predictive marker of diminished tamoxifen benefit

Sanne Løkkegaard, Daniel Eliáš, Carla L. Alves et al. · npj Breast Cancer · 2021 · 19 citations · Full text

Adoptive cell transfer therapy with ex vivo primed peripheral lymphocytes in combination with anti-PDL1 therapy effectively inhibits triple-negative breast cancer growth and metastasis

Odd Lilleng Gammelgaard, Mikkel G. Terp, Alexei F. Kirkin et al. · Molecular Cancer · 2024 · 13 citations · Full text